ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Does reintervention improve survival in recurrent glioblastoma? Facing a temporal bias in the literature
Acta Neurochirurgica
◽
10.1007/s00701-020-04432-4
◽
2020
◽
Vol 162
(8)
◽
pp. 1967-1975
Author(s):
Juan Delgado-Fernández
◽
Natalia Frade-Porto
◽
Guillermo Blasco
◽
Patricia González-Tarno
◽
Ricardo Gil-Simoes
◽
...
Keyword(s):
Recurrent Glioblastoma
◽
Temporal Bias
Download Full-text
Related Documents
Cited By
References
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
Yearbook of Neurology and Neurosurgery
◽
10.1016/s0513-5117(10)79224-3
◽
2010
◽
Vol 2010
◽
pp. 159-160
Author(s):
A.M. McKinney
Keyword(s):
Radiation Necrosis
◽
External Beam Radiation Therapy
◽
Recurrent Glioblastoma
◽
External Beam Radiation
◽
Dynamic Susceptibility
◽
Recurrent Glioblastoma Multiforme
◽
Beam Radiation
◽
Contrast Enhanced
◽
Perfusion Mr
◽
Perfusion Mr Imaging
Download Full-text
A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
Yearbook of Neurology and Neurosurgery
◽
10.1016/s0513-5117(10)79307-8
◽
2010
◽
Vol 2010
◽
pp. 109-110
Author(s):
J. Uhm
Keyword(s):
Single Dose
◽
Recurrent Glioblastoma
◽
Vascular Normalization
Download Full-text
Dynamic of Expression of 11 MicroRNAs in Recurrent Glioblastoma before and after Treatment with Radiotherapy and Chemotherapy
Journal of Neurological Surgery Part A Central European Neurosurgery
◽
10.1055/s-0035-1566419
◽
2015
◽
Vol 76
(S 02)
◽
Author(s):
Boštjan Matos
◽
Emanuela Boštjančič
◽
Mara Popović
◽
Damjan Glavač
Keyword(s):
Recurrent Glioblastoma
◽
Before And After
Download Full-text
Effect of Continuous Relatively High Dose Tamoxifen on Survival of Patients with Recurrent Glioblastoma Multifome
Journal of Cancer Prevention & Current Research
◽
10.15406/jcpcr.2016.06.00195
◽
2016
◽
Vol 6
(2)
◽
Author(s):
Bader Abdelmaksoud
Keyword(s):
Recurrent Glioblastoma
◽
High Dose
Download Full-text
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature
Journal of Neurosurgical Sciences
◽
10.23736/s0390-5616.16.03874-1
◽
2019
◽
Vol 63
(4)
◽
Cited By ~ 7
Author(s):
Salvatore Grisanti
◽
Vittorio D. Ferrari
◽
Michela Buglione
◽
Giorgio M. Agazzi
◽
Roberto Liserre
◽
...
Keyword(s):
Systematic Review
◽
Phase Ii
◽
Phase Ii Study
◽
Recurrent Glioblastoma
◽
Line Treatment
◽
Second Line
◽
Review Of Literature
Download Full-text
Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
Case Medical Research
◽
10.31525/ct1-nct04143425
◽
2019
◽
Author(s):
Keyword(s):
Response Prediction
◽
Recurrent Glioblastoma
Download Full-text
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) for People With Recurrent Glioblastoma With Elevated Mutational Burden
Case Medical Research
◽
10.31525/ct1-nct04145115
◽
2019
◽
Author(s):
Keyword(s):
Recurrent Glioblastoma
◽
Mutational Burden
Download Full-text
Faculty Opinions recommendation of Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.11771958.12863056
◽
2011
◽
Author(s):
Marc Chamberlain
Keyword(s):
Neurocognitive Function
◽
Recurrent Glioblastoma
Download Full-text
Faculty Opinions recommendation of Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717952694.793458250
◽
2012
◽
Author(s):
Guido Cavaletti
Keyword(s):
Tumor Progression
◽
Radiation Necrosis
◽
Recurrent Glioblastoma
◽
Perfusion Mri
◽
Definition Of
Download Full-text
Faculty Opinions recommendation of Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726074181.793537815
◽
2017
◽
Author(s):
Frank Lieberman
Keyword(s):
Recurrent Glioblastoma
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close